1. Home
  2. SRPT vs HTO Comparison

SRPT vs HTO Comparison

Compare SRPT & HTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • HTO
  • Stock Information
  • Founded
  • SRPT 1980
  • HTO 1985
  • Country
  • SRPT United States
  • HTO United States
  • Employees
  • SRPT N/A
  • HTO N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • HTO Water Supply
  • Sector
  • SRPT Health Care
  • HTO Utilities
  • Exchange
  • SRPT Nasdaq
  • HTO Nasdaq
  • Market Cap
  • SRPT 1.7B
  • HTO 1.8B
  • IPO Year
  • SRPT 1997
  • HTO N/A
  • Fundamental
  • Price
  • SRPT $11.93
  • HTO $48.61
  • Analyst Decision
  • SRPT Hold
  • HTO
  • Analyst Count
  • SRPT 28
  • HTO 0
  • Target Price
  • SRPT $48.42
  • HTO N/A
  • AVG Volume (30 Days)
  • SRPT 13.9M
  • HTO 236.1K
  • Earning Date
  • SRPT 08-06-2025
  • HTO 07-28-2025
  • Dividend Yield
  • SRPT N/A
  • HTO 3.46%
  • EPS Growth
  • SRPT N/A
  • HTO 12.16
  • EPS
  • SRPT N/A
  • HTO 2.98
  • Revenue
  • SRPT $2,233,371,000.00
  • HTO $766,656,000.00
  • Revenue This Year
  • SRPT $19.93
  • HTO $6.23
  • Revenue Next Year
  • SRPT N/A
  • HTO $5.34
  • P/E Ratio
  • SRPT N/A
  • HTO $16.30
  • Revenue Growth
  • SRPT 59.15
  • HTO 12.34
  • 52 Week Low
  • SRPT $10.42
  • HTO $44.91
  • 52 Week High
  • SRPT $150.48
  • HTO $62.18
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 28.15
  • HTO N/A
  • Support Level
  • SRPT $10.42
  • HTO N/A
  • Resistance Level
  • SRPT $14.54
  • HTO N/A
  • Average True Range (ATR)
  • SRPT 1.90
  • HTO 0.00
  • MACD
  • SRPT 0.13
  • HTO 0.00
  • Stochastic Oscillator
  • SRPT 12.14
  • HTO 0.00

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About HTO H2O America Common Stock

H2O America is a national investor-owned network of local water and wastewater utilities united by one purpose: delivering clean, high-quality water to the communities it calls home. Across approximately 407,000 water and wastewater service connections, the company invests in critical infrastructure to strengthen the water supply for generations to come.

Share on Social Networks: